Protective effect of Jolkinolide B on LPS-induced mouse acute lung injury.

[1]  Wan‐chun Sun,et al.  The Protective Effects of HJB-1, a Derivative of 17-Hydroxy-Jolkinolide B, on LPS-Induced Acute Distress Respiratory Syndrome Mice , 2016, Molecules.

[2]  Hong-yu Liu,et al.  Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice. , 2014, International immunopharmacology.

[3]  Baolan Li,et al.  Protective effects of scoparone against lipopolysaccharide-induced acute lung injury. , 2014, International immunopharmacology.

[4]  M. Vandenplas,et al.  HJB-1, a 17-hydroxy-jolkinolide B derivative, inhibits LPS-induced inflammation in mouse peritoneal macrophages. , 2014, International immunopharmacology.

[5]  P. Ward,et al.  Critical Role for the NLRP3 Inflammasome during Acute Lung Injury , 2014, The Journal of Immunology.

[6]  Xinjin Guo,et al.  Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice , 2014, Inflammation.

[7]  Yunhe Fu,et al.  Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. , 2014, International immunopharmacology.

[8]  Xiaobing Yu,et al.  Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways. , 2014, Biochemical and biophysical research communications.

[9]  Yang Li,et al.  LC-ESI-MS/MS analysis and pharmacokinetics of jolkinolide B, a potential antitumor active component isolated from Euphorbia fischeriana, in rat plasma. , 2014, Biomedical chromatography : BMC.

[10]  K. Brodsky,et al.  Identification of Hypoxia-Inducible Factor HIF-1A as Transcriptional Regulator of the A2B Adenosine Receptor during Acute Lung Injury , 2014, The Journal of Immunology.

[11]  Ying Tang,et al.  Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice. , 2014, European journal of pharmacology.

[12]  S. Herold,et al.  Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[13]  Meng-yao Guo,et al.  Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway. , 2013, International immunopharmacology.

[14]  P. He,et al.  Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways. , 2013, International journal of clinical pharmacology and therapeutics.

[15]  Xiao Chu,et al.  Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. , 2012, International immunopharmacology.

[16]  Dong-Hyun Kim,et al.  Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways. , 2012, Biochemical pharmacology.

[17]  Haihua Feng,et al.  Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway. , 2012, Biochemical and biophysical research communications.

[18]  Y. Shoyama,et al.  17-Hydroxy-jolkinolide B, a diterpenoid from Euphorbia fischeriana, inhibits inflammatory mediators but activates heme oxygenase-1 expression in lipopolysaccharide-stimulated murine macrophages. , 2012, International immunopharmacology.

[19]  P. Reddanna,et al.  Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. , 2009, Biochemical and biophysical research communications.

[20]  T. F. Murray,et al.  Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-α by equine monocytes , 2008 .

[21]  Steve Gerondakis,et al.  Coordinating TLR‐activated signaling pathways in cells of the immune system , 2007, Immunology and cell biology.

[22]  T. Mukherjee,et al.  Role of TNFα in pulmonary pathophysiology , 2006, Respiratory Research.

[23]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[24]  G. Zimmerman,et al.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. , 2005, American journal of respiratory cell and molecular biology.

[25]  S. Moochhala,et al.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome , 2004, The Journal of pathology.

[26]  R. H. Smith,et al.  A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. , 1997, Journal of immunological methods.